Ikaria Bioscience Pty Ltd
Ikaria Bioscience Pty Ltd
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RN5681 in Healthy Volunteers | Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, metabolic disease | Recruiting | Phase 1 | 2026-04-03 | NCT07347678 | |
| Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, familial chylomicronemia syndrome, familial lipoprotein lipase deficiency, hyperlipidemia, hypertriglyceridemia, metabolic disease | Active, not recruiting | Phase 1 / Phase 2 | 2025-12-30 | NCT06471543 | |
| Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 / Phase 2 | 2025-11-24 | NCT07245771 |